Development of new models for the analysis of Fc-FcRn interactions.

An important question remains as to which FcRn binding parameters, if any, correlate with the serum half-life of antibodies. In the present study, we used a BIACore surface plasmon resonance (SPR) device to study kinetic properties of antibody binding to FcRn at different pHs and under different binding reaction conditions. The ability of many different models to fit the data was tested. The previous models could not adequately explain all of the data collected. We now present models that have intuitive appeal and fit a broader range of data than previous models. Specifically, the model assumes that there are two forms of FcRn on the BIAcore chip and that, in addition to monomeric IgG, there is some aggregated IgG that can function as ligand. Although this model represents an improvement over previous models, it is still not globally valid for the entire range of data that was collected. Even with these limitations, the model provides a powerful new tool to analyze not only FcRn-IgG interactions but also other complex protein-protein interactions.

[1]  P. Bjorkman,et al.  High-affinity binding of the neonatal Fc receptor to its IgG ligand requires receptor immobilization. , 1997, Biochemistry.

[2]  A. West,et al.  The chicken yolk sac IgY receptor, a functional equivalent of the mammalian MHC-related Fc receptor, is a phospholipase A2 receptor homolog. , 2004, Immunity.

[3]  J J Distefano,et al.  DIMSUM: an expert system for multiexponential model discrimination. , 1992, The American journal of physiology.

[4]  R. Junghans.  Finally! the Brambell receptor (FcRB) , 1997, Immunologic research.

[5]  E. Ward,et al.  Delineation of the amino acid residues involved in transcytosis and catabolism of mouse IgG1. , 1997, Journal of immunology.

[6]  E. Ward,et al.  FcRn: the MHC class I-related receptor that is more than an IgG transporter. , 1997, Immunology today.

[7]  P. Bjorkman,et al.  Effects of receptor dimerization on the interaction between the class I major histocompatibility complex-related Fc receptor and IgG. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[8]  Anthony M Giannetti,et al.  Mechanism for Multiple Ligand Recognition by the Human Transferrin Receptor , 2003, PLoS biology.

[9]  Raimund J Ober,et al.  Compensation for loss of ligand activity in surface plasmon resonance experiments. , 2002, Analytical biochemistry.

[10]  B. Ober,et al.  The stoichiometry and affinity of the interaction of murine Fc fragments with the MHC class I-related receptor, FcRn. , 1996, Molecular immunology.

[11]  A. West,et al.  Crystal structure and immunoglobulin G binding properties of the human major histocompatibility complex-related Fc receptor(,). , 2000, Biochemistry.

[12]  G. Schwarz.  Estimating the Dimension of a Model , 1978 .

[13]  Leonard G. Presta,et al.  High Resolution Mapping of the Binding Site on Human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and Design of IgG1 Variants with Improved Binding to the FcγR* , 2001, The Journal of Biological Chemistry.

[14]  Jin‐Kyoo Kim,et al.  Identifying amino acid residues that influence plasma clearance of murine IgG1 fragments by site‐directed mutagenesis , 1994, European journal of immunology.

[15]  F. W. R. BRAMBELL,et al.  A Theoretical Model of γ-Globulin Catabolism , 1964, Nature.

[16]  R. Hansen,et al.  Pharmacokinetic/pharmacodynamic modeling of the effects of intravenous immunoglobulin on the disposition of antiplatelet antibodies in a rat model of immune thrombocytopenia. , 2003, Journal of pharmaceutical sciences.

[17]  P. Bjorkman,et al.  Crystal structure at 2.2 Å resolution of the MHC-related neonatal Fc receptor , 1994, Nature.

[18]  J. Fahey,et al.  FACTORS CONTROLLING SERUM GAMMA-GLOBULIN CONCENTRATION. , 1963 .

[19]  E. Ward,et al.  Multiple roles for the major histocompatibility complex class I- related receptor FcRn. , 2000, Annual review of immunology.

[20]  Jin‐Kyoo Kim,et al.  Localization of the site of the murine IgG1 molecule that is involved in binding to the murine intestinal Fc receptor , 1994, European journal of immunology.

[21]  E. Ward,et al.  Catabolism of the Murine IgGl Molecule: Evidence that Both CH2‐CH3 Domain Interfaces are Required for Persistence of IgGl in the Circulation of Mice , 1994 .

[22]  Raimund J. Ober,et al.  Increasing the serum persistence of an IgG fragment by random mutagenesis , 1997, Nature Biotechnology.